TDs / Ken O'Flynn

Official portrait of Ken O'Flynn

Ken O'Flynn

Independent Ireland Cork North-Central TD in this Dáil since 29 November 2024

Official Oireachtas profile

Portrait: © Houses of the Oireachtas (Oireachtas (Open Data) PSI Licence) · source file

9,005
questions asked
Oral and written, to government departments
86,377
words spoken in the chamber
Across 393 contributions. Plus 40 contributions from the chair, not counted
295
votes recorded
Each Yes, No or Abstained in a recorded vote
421
topics asked about
Across 20 departments

From the Dáil chamber only: committee meetings are not in this archive.

What they ask about

The subject headings the Oireachtas filed their questions under.

Who they ask

The departments their questions were addressed to.

Month by month

Low months are usually recesses, when the Dáil does not sit. The archive runs to 22 October 2026.

Questions asked 9,005 in all

Dec 2024Oct 2026

Contributions to debates 393 in all

Dec 2024Oct 2026
Show as a table
MonthQuestionsContributions
December 2024 0 1
January 2025 0 1
February 2025 17 20
March 2025 14 22
April 2025 24 16
May 2025 227 18
June 2025 49 14
July 2025 35 24
August 2025 0 0
September 2025 663 33
October 2025 297 9
November 2025 1,060 18
December 2025 621 2
January 2026 190 45
February 2026 911 14
March 2026 387 38
April 2026 691 31
May 2026 2,122 20
June 2026 635 22
July 2026 289 11
August 2026 0 2
September 2026 347 12
October 2026 426 20

Debates they spoke in most

Plus 188 contributions in the regular slots, such as Leaders' Questions and Priority Questions. Speech from the chair is not counted.

Asked about similar topics

Worked out by computer from the subject headings of each TD's questions, giving more weight to headings few TDs use. It shows shared subjects, not shared views.

Party, constituency and offices

  1. constituency Cork North-Central 29 November 2024 to now
  2. party Independent Ireland 29 November 2024 to now
Ken O'Flynn Written 26 May 2026 · to Health
1427. Deputy Ken O'Flynn asked the Minister for Health whether the HSE centrally monitors variation between Health Regions in the implementation of agency staff conversion policies; and whether any region has been identified as underperforming. [39787/26]
Ken O'Flynn Written 26 May 2026 · to Health
1428. Deputy Ken O'Flynn asked the Minister for Health whether any national targets, timelines or KPIs have been established for reducing long-term agency staffing dependency across the health service. [39788/26]
Ken O'Flynn Written 26 May 2026 · to Health
1429. Deputy Ken O'Flynn asked the Minister for Health the services or specialties currently most dependent on long-term agency staffing, by Health Region. [39789/26]
Ken O'Flynn Written 26 May 2026 · to Health
1430. Deputy Ken O'Flynn asked the Minister for Health whether the HSE assesses the impact of repeated agency staff turnover on continuity of care, patient outcomes, or service quality. [39790/26]
Ken O'Flynn Written 26 May 2026 · to Health
1431. Deputy Ken O'Flynn asked the Minister for Health whether any independent audit or value-for-money review has been conducted regarding agency staff conversion measures introduced in July 2025. [39791/26]
Ken O'Flynn Written 26 May 2026 · to Health
1432. Deputy Ken O'Flynn asked the Minister for Health whether agency staffing suppliers are performance monitored nationally; and whether any suppliers have been subject to sanctions, restrictions, or removal from approved frameworks since 2020. [39792/26]
Ken O'Flynn Written 26 May 2026 · to Health
1433. Deputy Ken O'Flynn asked the Minister for Health whether any HSE information systems operate with formally defined acceptable error-rate thresholds; and if she will provide details by system category. [39810/26]
Ken O'Flynn Written 26 May 2026 · to Health
1434. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the frequency of identified human-data-entry errors across major clinical and administrative systems; and if so, the annual figures recorded since 2020. [39811/26]
Ken O'Flynn Written 26 May 2026 · to Health
1435. Deputy Ken O'Flynn asked the Minister for Health whether any HSE systems trigger automatic escalation procedures when data quality issues exceed predefined thresholds; and if she will provide details. [39812/26]
Ken O'Flynn Written 26 May 2026 · to Health
1436. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a national register of serious data-quality incidents affecting patient care, referrals, waiting lists, prescribing, diagnostics or scheduling systems. [39813/26]
Ken O'Flynn Written 26 May 2026 · to Health
1437. Deputy Ken O'Flynn asked the Minister for Health the number of incidents since 2020 in which inaccurate or incomplete data entry contributed to delayed treatment, incorrect referrals, patient-safety incidents or financial overpayments. [39814/26]
Ken O'Flynn Written 26 May 2026 · to Health
1438. Deputy Ken O'Flynn asked the Minister for Health whether any independent audit has assessed the cumulative national risk posed by fragmented or inconsistent data-quality controls across HSE systems. [39815/26]
Ken O'Flynn Written 26 May 2026 · to Health
1439. Deputy Ken O'Flynn asked the Minister for Health whether regional HSE bodies operate under uniform national data-quality standards and escalation mechanisms; and if she will provide details of any regional variation. [39816/26]
Ken O'Flynn Written 26 May 2026 · to Health
1440. Deputy Ken O'Flynn asked the Minister for Health who holds ultimate accountability within the HSE for national data-quality assurance and human-error mitigation across clinical and operational systems. [39817/26]
Ken O'Flynn Written 26 May 2026 · to Health
1441. Deputy Ken O'Flynn asked the Minister for Health whether any internal risk assessment, service review, or operational assessment identified the absence of SCAN nurses in the HSE Mid-West as a deficiency, unmet service need, or patient-safety concern at any time since 2020. [39818/26]
Ken O'Flynn Written 26 May 2026 · to Health
1442. Deputy Ken O'Flynn asked the Minister for Health when the HSE first identified the need for dedicated SCAN nurses in the HSE Mid-West region. [39819/26]
Ken O'Flynn Written 26 May 2026 · to Health
1443. Deputy Ken O'Flynn asked the Minister for Health whether the HSE conducted any benchmarking comparing SCAN coverage across HSE regions prior to approving funding for two SCAN nurses in the Mid-West. [39820/26]
Ken O'Flynn Written 26 May 2026 · to Health
1444. Deputy Ken O'Flynn asked the Minister for Health whether any adverse incident reviews, crisis response reviews, or emergency department escalation reviews referenced the absence of SCAN services in the Mid-West. [39821/26]
Ken O'Flynn Written 26 May 2026 · to Health
1445. Deputy Ken O'Flynn asked the Minister for Health how many dedicated SCAN nurses are currently operating in each HSE region. [39822/26]
Ken O'Flynn Written 26 May 2026 · to Health
1446. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has established recommended staffing ratios or population benchmarks for SCAN services nationally. [39823/26]
Ken O'Flynn Written 26 May 2026 · to Health
1447. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE considers the provision of only two SCAN nurses sufficient for the Mid West population and crisis demand profile. [39824/26]
Ken O'Flynn Written 26 May 2026 · to Health
1448. Deputy Ken O'Flynn asked the Minister for Health when the two approved SCAN nurse posts for the Mid-West are expected to become operational. [39825/26]
Ken O'Flynn Written 26 May 2026 · to Health
1449. Deputy Ken O'Flynn asked the Minister for Health whether the posts have been advertised, filled, or remain vacant. [39826/26]
Ken O'Flynn Written 26 May 2026 · to Health
1450. Deputy Ken O'Flynn asked the Minister for Health whether any business case or service development proposal supporting the Mid-West SCAN expansion will be published. [39827/26]
Ken O'Flynn Written 26 May 2026 · to Health
1451. Deputy Ken O'Flynn asked the Minister for Health whether the HSE formally reviewed reimbursement, managed access, or pricing decisions relating to omaveloxolone (skyclarys) in France, Germany, Italy, Spain, Belgium, the Netherlands or the United Kingdom as part of the Irish reimbursement assessment process; and if she will provide details of any such comparative analysis undertaken. [39831/26]